Muscle & strength: what grip strength predicts.

A handheld dynamometer is a simple instrument. You squeeze it, it reads out a force in kilograms, and a tester records the result under a standard protocol. In the PURE study of 139,691 adults across 17 countries, that reading predicted death from any cause more strongly than systolic blood pressure did (PURE, Lancet 2015). For a measurement most people have never had done, that is a striking place to land.

The number is worth taking apart. "Predicts" and "causes" are different claims, and the gap between them decides what you should actually do about it.

The signal is consistent across populations

In PURE, each 5 kg lower baseline grip strength was associated with a 16% higher hazard of all-cause death (HR 1.16) and a 17% higher hazard of cardiovascular death (HR 1.17) (PURE, Lancet 2015). That compared people who differed in strength at baseline. It did not follow individuals losing strength over time, and grip showed no significant association with fall injury or fracture in that cohort.

The pattern repeats in a larger population. UK Biobank followed just over half a million adults for about seven years and found a similar slope: each 5 kg lower grip was associated with roughly 20% higher all-cause mortality in women and 16% in men (Celis-Morales, BMJ 2018). The associations were similar after excluding deaths in the first two years — which makes imminent undiagnosed illness an incomplete, but still possible, explanation. It lowers the odds that already-sick, declining people are driving the whole result. It does not rule that out.

Why would a grip test carry this much information? Grip is a proxy. Nobody thinks the forearm is load-bearing for survival. It is a convenient, repeatable readout of muscular strength, which tends to move with overall physical capacity. Two things often get blurred here and are worth keeping apart: strength, which a dynamometer measures, and muscle mass, which a DEXA scan estimates as lean tissue. They are related but not interchangeable, and the mortality findings above are specifically about grip strength, not about lean mass on a scan.

Why strength and muscle plausibly matter

Some background physiology is widely accepted, even though these three studies were not designed to prove it. Skeletal muscle is a major site where the body clears glucose from the blood, which links it to how you handle blood sugar over time. Muscle also acts as a physiological reserve: capacity to draw on during illness, injury, or recovery. The age-related loss of muscle and strength has a clinical name, sarcopenia, and it tends to progress quietly for years before it shows up as trouble rising from a chair or climbing stairs. These points are offered as accepted background, not as effects demonstrated by the grip-mortality data.

There is also observational evidence on training itself. A meta-analysis of prospective cohorts found that people who did muscle-strengthening activity, compared with those who did none, had about 15% lower all-cause mortality (RR 0.85), along with roughly 17% lower cardiovascular disease risk, 12% lower total cancer risk, and 17% lower diabetes incidence (Momma, Br J Sports Med 2022). The modeled association looked strongest at around 30 to 60 minutes per week, and what happens at higher volumes was uncertain. These are pooled observational cohorts, not a controlled trial; the authors rated the overall certainty of evidence as generally very low (low for the diabetes outcome), with high heterogeneity for the mortality, cardiovascular, and cancer results; and they could not directly test how session frequency mattered.

The honest limits

Grip strength is a prognostic marker. It tracks with mortality risk across large groups the way a thermometer tracks with illness. That is not the same as proving that raising your grip number, or adding muscle, changes how long you live. People who train differ from people who don't in many ways that observational studies can't fully separate. So resistance training should not be described as proven to extend lifespan; the cited evidence doesn't carry that sentence.

What can be said more plainly: resistance training is generally safe and well studied, and it reliably improves strength and physical function. It is not risk-free for everyone. Depending on cardiovascular, orthopedic, or other conditions, some people need medical clearance or a modified program first.

What's reasonable to do

Measure, if it helps you. A grip test is cheap and repeatable, and DEXA can estimate lean mass. Read against age- and sex-based norms, they give you a baseline. They describe where you stand; they are not a promise about your future.

Then train against resistance. Public-health guidance recommends muscle-strengthening activity at least twice a week [cite: WHO/ACSM guideline — add in review]. The cohort data above measured weekly minutes rather than session frequency, so treat "twice a week" as general guidance, not a finding from these studies. Squats, presses, rows, and loaded carries, done consistently and with gradually increasing load, are the ordinary tools. The point is building and keeping strength and function, not chasing a single number.

How Peak You fits in

We measure grip and, where it's appropriate, lean mass early in a membership, so you and your clinician start from a real baseline rather than an impression from the mirror. A clinician then sets a resistance plan matched to your starting point and any medical constraints, and we re-test over time to see whether strength and body composition are holding or improving. The boundary matters here: we measure a marker that is associated with risk and we support your training. We do not claim, and the evidence does not show, that our testing or our protocols extend life or lower your personal mortality.

The honest goal is simple. Build strength and physical function while you can, and work to keep them as you age. That is worth doing for how you live day to day, independent of what it may or may not add to how long.

Frequently asked